Healthy Livers, Healthy Lives’ Chair Jeff Lazarus shares with the Surfers the importance of political will in building a consensus for global MASLD public health policy.
Jeff Lazarus, Chair of Healthy Livers, Healthy Lives, joins the Surfers to discuss this global SLD Public Health coalition. and the role of “top-down” solutions.
This final conversation from #SLDThinkTank 2024 start with the question, “Next year?” Two key foci emerge: broadening the set of groups in the meeting and focusing more broadly on the concept of preventive hepatology.
Global Liver Institute Vice President of Liver Programs Jeff McIntyre describes the rational behind GLI’s 2024 theme, after which Mike Betel and Roger Green share reactions.
Patient advocates Jeff McIntyre (Global Liver Institute) and Mike Betel (Fatty Liver Alliance, Liver Action Network) join Louise Campbell and Roger Green to discuss GLI’s premier MASH patient event, now known as Global Fatty Livery Day.
Hepatologist Tim Jobson, co-founder of Predictive Health Intelligence, joins Louise Campbell and Roger Green to provide an update on PHI’s work and discuss implications for databases, patient recruitment and special population issues.
Hannes Hagstrom and the Surfers consider the ways that increased access to in-office screening will affect clinical care pathways, with special focus on the role of primary care practices.
Hannes Hagstrom joins the Surfers to discuss the value of VCTE or other in-office MASLD monitoring due to the results providing prognoses comparable or superior to biopsy and feedback for patient self-management.
Fatty Liver Alliance Founder Mike Betel joins Roger Green to consider how patient incentives to participate in MASH clinical trials might need to change now that prescribers have an approved drug for treating MASH patients.
Last Thursday, March 14, Rezdiffra (resmetirom) became the first drug approved in the US for MASH. Five leading North American MASLD patient advocates join the Surfers to discuss their feelings about this approval along with the opportunities and challenges that lie ahead.
